santa cruz biotechnology, inc.
SCBT Logo

Willkommen!        Produkt(e) im Warenkorb.     Bestellen
 

MAPK Inhibitors and Activators

  • 5-Iodotubercidin
    Potent and competitive inhibitor of MAP Kinase ERK2. Inhibitor of Adenosine Kinase and Ser/Thr-specific kinases (casein kinase 1 and PKA).
    Katalog #CAS NummerSummenformelMenge
    sc-353124386-93-4C11H13IN4O41 mg/5 mg
  • AG 126
    Blocks production of tumor necrosis factor-α (TNF-α) and nitric oxide in macrophages. AG-126 prevents lipopolysaccharide-induced lethal toxicity in mice by blocking tyrosine phosphorylation of p42 MAPK protein substrate.
    Katalog #CAS NummerSummenformelMenge
    sc-3528118409-62-4C10H5N3O35 mg/25 mg
  • CAY10571
    Pyridinylimidazoles, often called CSAIDs, are a class of anti-inflammatory compounds that suppress the synthesis of cytokines in human monocytes and inhibit eicosanoid productio. Because of its high specificity, one predominant pyridinylimidazole, SB203580, is frequently used to inhibit p38 MAPK, the tyrosine kinase activated by inflammatory cytokines and environmental stresses. CAY10571 is an analog of SB203580 that inhibits IL-1 production in the human monocytic cell line THP with an IC50 value of 0.20 µM and binds CSAID binding protein, a serine/threonine kinase homologous to p38, inhibiting its kinase activity with an IC50 value of 0.03 µM. This chemical also inhibits 5-lipoxygenase production in RBL-1 cells with an IC50 value of 24 µM.
    Katalog #CAS NummerSummenformelMenge
    sc-223869152121-46-5C21H16FN3O2S5 mg/10 mg
  • CGP 57380
    A selective inhibitor of mitogen-activated protein kinase-interacting kinase 1 (MNK1). Effectively inhibits eIF4E phosphorylation.
    Katalog #CAS NummerSummenformelMenge
    sc-202993522629-08-9C11H9FN65 mg
  • Coumermycin A1
    Shown to be a cell permeable antibiotic that induces activation of JAKs via autophosphorylation. Also reported to cause cell proliferation.
    Katalog #CAS NummerSummenformelMenge
    sc-2008824434-05-3C55H59N5O205 mg/25 mg
  • U-0126
    A selective MAPK and ERK inhibitor, displaying a preference for MEK1 and MEK2.
    Katalog #CAS NummerSummenformelMenge
    sc-222395109511-58-2C18H16N6S21 mg/5 mg
  • ERK Inhibitor II, FR180204
    A novel ERK-selective inhibitor that can permeate the cell. The compound has been reported to inhibit ERK1 (Ki=0.31μM), ERK2 (Ki=0.14 μM), TGFβ-induced AP-1 activation and acts as a competitive inhibitor of ATP.
    Katalog #CAS NummerSummenformelMenge
    sc-203945865362-74-9C18H13N71 mg
  • GW 5074
    An Inhibitor of Raf-1 kinase, PMA-mediated activation of ERK1/2, and blocks neurodegeneration. Used in Ras/Raf-1/ERK pathway studies.
    Katalog #CAS NummerSummenformelMenge
    sc-200639220904-83-6C15H8Br2INO25 mg/25 mg
  • JX-401
    JX-401 is a potent reversible inhibitor of p38alpha by reversibly binding MAPK p38alpha and has blocked differentiation of L8 myoblasts to myotubes.
    Katalog #CAS NummerSummenformelMenge
    sc-200687349087-34-9C21H25NO2S1 mg/10 mg
  • MK2a Inhibitor
    A p-amidophenolic compound that selectively inhibits the phosphorylation of MK2a by p38α in a non-ATP-competitive manner.
    Katalog #CAS NummerSummenformelMenge
    sc-20313841179-33-3C22H20FNO210 mg
  • p38 MAP Kinase Inhibitor
    A potent p38 MAP kinase inhibitor (IC50 = 35 nM).
    Katalog #CAS NummerSummenformelMenge
    sc-204157219138-24-6C20H13ClFN3O500 µg
  • p38 MAP Kinase Inhibitor III
    Methylsulfanylimidazole compount that is cell-permeable and acts as a potent, selective, and ATP competitive p38 MAP kinase inhibitor. Has been shows to effectively suppress LPS-induced cytoking release in vitro and in vivo.
    Katalog #CAS NummerSummenformelMenge
    sc-204158581098-48-8C23H21FN4S1 mg
  • p38 MAP Kinase Inhibitor IV
    A cell permeable sulfone compound which functions as an ATP-competitive inhibitor of p38α and p38β MAP Kinases.
    Katalog #CAS NummerSummenformelMenge
    sc-2041591638-41-1C12H4Cl6O4S10 mg
  • p38 MAP Kinase Inhibitor V
    A cell-permeable trisubstituted pyrazole compound that acts as a highly potent ATP-competitive inhibitor of CK1 and p38.
    Katalog #CAS NummerSummenformelMenge
    sc-204160271576-77-3C19H20ClN51 mg
  • p38 MAP Kinase Inhibitor VIII
    A synthetic 4-aminobenzophenone small molecule inhibitor of p38α and p38β MAP kinase. Blocks the release of TNF-α and proinflammatory interleukins.
    Katalog #CAS NummerSummenformelMenge
    sc-203173321351-00-2C20H16BrClN2O5 mg
  • PD 169316
    A potent, cell-permeable, and selective p38 MAP kinase inhibitor (IC50 = 89 nM). Inhibition of p38 MAP kinase by PD 169316 blocks apoptosis induced by trophic factor withdrawal in non-neuronal and neuronal cell lines.
    Katalog #CAS NummerSummenformelMenge
    sc-204168152121-53-4C20H13FN4O21 mg
  • PD 184,352
    An inhibitor of MEK, blocks MAPK activity and slows proliferation of colon tumor cells in mice.
    Katalog #CAS NummerSummenformelMenge
    sc-202759212631-79-3C17H14ClF2IN2O21 mg/5 mg
  • PD 184161
    A strong and selective inhibitor of MEK1/2; more effective at inhibiting phosphorylation of ERK1/2 than the selective MEK inhibitors, PD098059 and U0126.
    Katalog #CAS NummerSummenformelMenge
    sc-222141212631-67-9C17H13BrClF2IN2O21 mg/5 mg
  • PD 198306
    Cell-permeable amino-benzamide compound that acts as a potent and non-ATP-competitive inhibitor of MEK1/2.
    Katalog #CAS NummerSummenformelMenge
    sc-203180212631-61-3C18H16F3IN2O25 mg
  • PD 98059
    PD 98059 is a potent, selective and reversible cell permeable inhibitor of MEK-1, inducer of GSTA2 and enhancer of glutathione.
    Katalog #CAS NummerSummenformelMenge
    sc-3532167869-21-8C16H13NO31 mg/5 mg
  • SB 202190
    A pyridinyl imidazole that inhibits the p38 pathway. It can also induce apoptosis, and phosphorylate and activate MLK3.
    Katalog #CAS NummerSummenformelMenge
    sc-202334152121-30-7C20H14FN3O1 mg/5 mg
  • SB 203580
    Highly specific inhibitor of p38 MAP kinase. Blocks activation of MAPKAP Kinase-2, yet does not disrupt JNK activity. A useful tool to assess the physiological roles of p38, and for deriving and maintaining embryonic stem cells.
    Katalog #CAS NummerSummenformelMenge
    sc-3533152121-47-6C21H16FN3OS1 mg/5 mg
  • SB 203580 (hydrochloride)
    A pyridinyl imidazole inhibitor that can suppress proliferative activity on cytokine-activated lymphocytes. Additionally found to inhibit MAPKs.
    Katalog #CAS NummerSummenformelMenge
    sc-204900869185-85-3C21H16FN3OS ·HCl5 mg/10 mg
  • SB 239063
    Katalog #CAS NummerSummenformelMenge
    sc-220094193551-21-2C20H21FN4O25 mg/25 mg
  • SB220025
    Potent and specific inhibitor of human p38 (SAPK2a). Potent inhibitor of angiogenesis and as an inhibitor of TNF-α production.
    Katalog #CAS NummerSummenformelMenge
    sc-202804165806-53-1C18H19FN6500 µg
  • SD-169
    A compound that inhibits p38α MAPK and acts as an ATP competitive inhibitor of p38 kinase. Described to decrease the expression of HSP60, insulitis, and beta cell death.
    Katalog #CAS NummerSummenformelMenge
    sc-2006931670-87-7C9H8N2O10 mg/50 mg
  • SL-327
    A selective inhibitor of MEK1 and MEK2. Also inhibits ERK1, MEK-3/p38, MEK-4, JNK, and PKC at higher concentrations.
    Katalog #CAS NummerSummenformelMenge
    sc-200685305350-87-2C16H12F3N3S1 mg/10 mg
  • XRP44X
    Ras-Net (Elk-3) pathway inhibitor (IC50 = 10-20 nM). Indirectly inhibits Net phosphorylation upstream of Erk1/2 activation. Mediates G2-M cell cycle arrest. Suppresses growth of multiple cell types (IC50 ~ 2 nM). Inhibits angiogenesis and acts as a microtubule depolymerizing agent in vitro.
    Katalog #CAS NummerSummenformelMenge
    sc-204404729605-21-4C21H21ClN4O10 mg/50 mg